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Abstract. A pharmacological study of aqueous extract of the aerial parts of Ajuga iva L. was 
performed using animal models. The administration of different doses (0.025 g/mL; 0.05 g/ mL; 0.13 
g/mL; 0.2 g/ml and 0.4 g/mL) of the aqueous extract caused a decrease in the number of abdominal 
cramps in the same time interval. Doses of 0.13 g/mL, 0.2 g/mL, 0.4 g/mL generated an increase in the 
percentage of inhibition of contractions of 79.78±4.64, 85.39±4.29 to 96±5.20, respectively, compared 
to the control (77.53±3.80). These results indicate that doses 0.13 g/mL, 0.2 g/mL and 0.4 g/mL of 
aqueous extract of Ajuga iva L. are more effective than the analgesic effect of ibuprofen. The single 
and repeated administration of aqueous extract (0.15 g/L) orally for 3 weeks reduced the blood glucose 
levels significantly (70%) in diabetic rats compared with the percentage reduction levels in rats of 
control group treated with Diabenil ® (47.81%). The administration of 0.15 g/L aqueous extract 
of the plant decreased blood glucose levels. 
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INTRODUCTION 
 
Recently, particular attention was paid to plants rich in polyphenols, which have 
perfect antioxidant effects. The Lamiaceae family is particularly rich in polyphenols. Ajuga 
iva L., a spontaneous species of this plant family, grows in the Mediterranean area and often 
develops in severe environmental conditions (salinity, high light, drought). This plant is 
known by its therapeutic value (El Hilaly and Youssi, 2002). 
In the traditional therapy, this plant is used for its hepato-protective, cholesterolytic, 
hypoglycemic and analgesic capacities (Bnouham et al., 2002).  
  This study examines the effect of the aqueous extract of Ajuga iva L. on the 
antispasmodic activity and levels of blood glucose in diabetic rats induced by Alloxan. 
 
MATERIALS AND METHODS 
 
The plant was collected in the area of Ain Defla (North of Algeria) in May–June 
2010. Plant material was authenticated in Plant Taxonomy Laboratory (Department of 
Biology, Saâd Dahlab University of Blida). The leaves were dried in darkness between 25 and 
28°C, then crushed and converted into powder from which the aqueous extracts were 
prepared.  
Adult female Wistar rats weighing 190 to 200 g (5 groups of 6 rats each) were 
selected and housed under standard environmental conditions (23°C, 12h/12 h light/dark 
cycle) with free access to water and ad libitum standard laboratory diet. All the animals used 
in these experiments were treated with humane care. 
Preparation of aqueous extract. The aqueous extracts were freshly prepared daily 
just before administration. Ten grams of the dried powdered plants leaves were boiled at 
 340 
 
100°C in 100 mL of distilled water for 15 min, then aqueous extract was filtered with a 
millipore filter in order to remove the macromolecules. Thereafter, rats receive subcutaneous 
injection of this filtrate solution. 
Determination of hypoglycemic activity. Three doses (0.05 g/mL, 0.1 g/mL, 0.15 
g/mL) of the infusion from the dry powder plant were used on animals, which were divided 
into five groups and treated as follow:  
 Group 1 (control 1): Alloxan monohydrate (diabetic stimulator)  + physiologic water 
 Group 2 (control 2): Alloxan monohydrate + antidiabetic medication (Diabenil ®) 
 Group 3 (test1): Alloxan monohydrate + aqueous extract at dose 0.05g/mL, 
 Group 4 (test2): Alloxan monohydrate + aqueous extract at a dose 0.1g/mL, 
 Group 5 (test3): Alloxan monohydrate + aqueous extract at a dose 0.15 g/mL. 
Blood samples were then collected from the rats and immediately followed by the 
three steps of experiments. Experiments were conducted in three steps: 
Step 1: determination of base blood glucose level at T0, which is at the beginning of 
the experiment. The rats were fasted 18 hours before the determination of the base blood 
glucose level (T0) was determined by an enzymatic colorimetric method (glucose oxidase 
GOD), (measured spectrophotometrically at 505 nm). 
Step 2: diabetes mellitus (hyperglycemia) was induced in rats by subcutaneously 
administration of 1 ml of Alloxan monohydrate solution at (150 mg/kg). The glucose level for 
each rat was noted 72 hours after the administration of Alloxan. 
Step 3: 1ml/rat of the different solutions used: (physiologic water, Diabenil ® and 
aqueous extracts) were orally administrated daily for 3 weeks and the blood glucose level was 
measured. The percentage of blood glucose reduction (at each period) was calculated using 
the following formula: 
P = (Ci-Ce) / Ci x 100 
P: Percentage of blood glucose reduction 
Ci: the average glucose level (g.L-1) in control1 group (water) and Ce, the average glucose 
level in tests groups (test 1, test 2 and test 3). 
The blood glucose level of the 5 batches (water, Diabenil ®), test 1, test 2 and test 3), 
was measured four times: at the beginning of diabetes (T0), one week after (T1), two weeks 
after (T2) and three weeks after (T3) 
Statistical analysis. Homogeneity of data variances was verified using Levene test. 
Student t-test was then performed to compare changes in blood glucose levels between the 
different tests samples and control group (water) for each period. Values are given as mean 
±SE (SE: standard error of mean) 
Determination of antispasmodic activity: was performed according to the method 
described by Koster et al. (1959) and modified by Collier et al. (1968). Five doses of aqueous 
extract were administered to mice divided into 7 groups of six males (NMRI strain, weight 
180±2g) each. The positive control received an Ibuprofen diluted in physiological water (9‰) 
at 200 mg/Kg. 
Control Group    Physiological water  
Positive Control Group  Ibuprofen = 200mg/Kg 
Group Test 1    Dose 1 = 0.025 g /mL 
Group Test 2    Dose 2 = 0,05g/mL 
Group Test 3    Dose 3 = 0,13g/mL 
Group Test 4   Dose 4 = 0,2 g/mL 
Group Test 5    Dose 5= 0,4g/mL 
At T0: injection by intra-peritoneal dose of 0.5 mL of the aqueous extract equivalent for each 
lot. 
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After 30 min: all mices received 0.2 mL of acetic acid solution at 1% by intra-peritoneal 
pathway. 
After 5 min:  spasms number directly observed in mice for 10 minutes.  
The percentage of reduction of muscle spasms (percentage of protection PP) was calculated 
using the following formula: 
PP = Average spasms control group - Average spasms test group 
Average spasms of control 
Comparison of average measurements between batches was made using the Student 
test (p<0.05). 
 
RESULTS AND DISCUSSIONS 
 
Results showed (Tab. 1) that at T0, the average blood glucose of Diabenil ® group, 
tests E1, E2 and E3 were comparable to those of the control group (water). No significant 
effects were observed (p=0.071) for the control Diabenil®, test E1 (p=0.085), test E2 
(p=0.127) and test E 3 (p=0.335) respectively. 
Tab. 1 
The variation of glycemia in diabetic rats in response to Ajuga iva L. - Therapy 
 
T0 T1 T2 T3 
 Glycemia  
(mg.l-1) 
Glycemia 
(mg.l-1) 
Percentage 
Reduction  
Glycemia     
(mg.l-1) 
Percentage 
Reduction 
Glycemia 
(mg.l-1) 
Percentage 
Reduction 
Water 2.58±0.03 2.37±0.02 8.20±2.17 2.22±0.01 14.20±1.81 1.80±0.04 30.15±3.24 
Diabenil 2.78±0.09 2.54±0.10 8.52±6.75 2.22±0.07 20.28±6.12 1.45±0.02*** 47.81±5.42 
E1 2.78±0.09 2.39±0.10 14.01±7.56 1.89±0.01*** 32.04±4.75 1.79±0.03 35.87±5.62 
E2 2.76±0.09 2.51±0.13 8.77±8.48 1.74±0.06*** 36.72±6.67 1.57±0.04** 43.19±6.12 
E3 2.70±0.10 2.28±0.11 15.52±8.65 1.44±0.10*** 46.63±9.44 1.00±0.03*** 62.96±7.30 
 
Comparable results for the first week were noted where the average blood glucose 
level of all groups were comparable to that of the control group (control-Diabenil ®) with no 
significant differences (p=0.134 for Diabenil®, p=0.835 for test E1, p=0.332 for test E2 and 
p=0.454 for test E3). In the second week, the average blood glucose level of Diabenil ® group 
was comparable to that of control group level (p=1.00) but highly significant differences 
(<0.001) were noted in the blood glucose level averages (p<0.0001, p=0.0003 and p=0.0006) 
for test 1, test 2 and test 3 respectively. In the third week, the average blood glucose level for 
test 1 group was comparable to that of control group (p=0.738), but very highly significant 
differences were found between the levels of control and Diabenil® groups (p<0.0001), 
control and test 2 groups (p=0.0018), and control and test 3 groups (p<0.0001).  
Only the aqueous extract of the plant at the concentration of 0.15 g.L-1 was effective 
in reducing blood glucose levels to nearly normal dose (≈1.00 g.L-1). The hypoglycemic effect 
of this aqueous extract exceeds Diabenil® level in the 3rd week of treatment with a percentage 
reduction of 62.96% against only 47.81% for Diabenil®. Theses results allow us to say that 
the aqueous extract at the concentration 0.15 g.mL-1 is more effective than Diabenil classic 
therapy. 
Presently, it is not possible to identify the exact mechanism of the hypoglycemic 
effect. According to Novoes-Penda (2005), Ajuga iva L. has no effect on the concentration of 
plasma insulin. Works carried out on some species of the same family have shown that the 
hypoglycemic effect of these plants is due to an extra-pancreatic mechanism to know about 
stimulation of peripherals tissues on glucose utilization (Horton, 2003; El-Hilaly and Youssi, 
2002; Jimens et al., 1986). The phyto-chemical analysis of the plant revealed the presence of 
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flavonoids, which could be responsible for the hypoglycemic effect (Eddouks et al., 2005). 
According to some recent studies, the flavonoids glycosides contribute to the decrease in 
blood glucose level (Maghrani et al., 2005).  
Antispasmodic activity results. (Tab. 2) After injection of acetic acid to the control 
group of mice, an average of 35.6±0.51 abdominal cramps was recorded after 10 min. After 
administration of different doses (0.025, 0.050, 0.130, 0.200 and 0.400 g/mL) of the aqueous 
extract of Ajuga iva L., the number of abdominal cramps decreased from 10.00 to 1.20 
spasms. The percentage inhibition of contractions, meanwhile, increased from 71.91% to 
96.63%. Comparable variables (p=0.44>0.05, Levene test) and   number of spasms for the 7 
groups (F=338.0 and p=0.00000 ANOVA test) found indicated very highly significant 
difference. In the control group, the average number of spasms was significantly higher 
(35.60±0.51), followed by the positive control (ibuprofen) as showed by Tukey HSD test. 
Numbers of spasms were comparable for groups 1 and 2 (average between 10.00 and 8.00) 
while groups 3 and 4 were also comparable (average between 7.20 and 5.20), and finally 
group 5 presented the average number of spasms significantly lower (1.20±0.80).  
                Tab.2  
Number of spasms (± SEM) and percentages of protection 
 
Lots Average number of spasms Percentage of protection 
Control 35.60±0.51a 0.00 
Control+ 8.00±0.45b,c 77.53±3.80 
Lot 1 10.00±0.71c 71.91±4.45 
Lot 2 8.60±0.40b,c 75.84±3.64 
Lot 3 7.20±0.73b,d 79.78±4.64 
Lot 4 5.20±0.58d 85.39±4.29 
Lot 5 1.20±0.80e 96.63±5.06 
 
These results indicate that Ajuga iva L. has a more analgesic effect than ibuprofen 
which causes pain inhibition of 77.53±3.80% while the aqueous extract of Ajuga iva L. 
caused 85.39±4.29% and 96.63±5.06 for doses of 0.2 et 0.4g/mL respectively. 
The aqueous extract of Ajuga iva contains flavonoids and saponins, which are 
inhibitors of prostaglandin and inflammation (Alaoui et al., 1998). Deraedt et al. (1980) have 
revealed high levels of prostaglandin PGE2α and PGEα in peritoneal exudates of rats after 
injection of acetic acid. Some authors have observed in the same conditions, the release of 
mediators of the sympathetic nervous system (Durate et al., 1988; Hokanson, 1978; Neo et 
al., 2005). 
The effects of aqueous extract of Ajuga iva could be related to inhibition of 
lipoxygenase and/or cyclooxygenase (Franzotti et al., 2002; Gupta et al., 2005). Indeed, 
inhibition of its enzyme causes a decrease in peripheral pain (Griswold et al., 1991; Mylari et 
al., 1990; Ojewole, 2007). 
 
CONCLUSION 
 
In conclusion, this study has showed that the aqueous extracts of Ajuga iva leaves 
possess a significant hypoglycemic effect in alloxan-induced diabetic rats. The mechanism of 
this pharmacological effect seems to be related to beta extra-pancreatic stimulation. 
The antispasmodic and hypoglycemic properties are probably related to the presence 
of flavonoids, phenols and saponins highlighted by the phyto-chemical screening. Subsequent 
experiments using purified extracts should be considered to identify precisely the compounds 
responsible of these activities and to understand their action mechanisms. 
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